A carregar...

Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia

BACKGROUND: According to the American Psychiatric Association Clinical Practice Guidelines for schizophrenia, second-generation antipsychotics may be specifically indicated for the treatment of depression in schizophrenia. We examined the impact of these medications on symptoms of depression using t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Psychiatry
Main Authors: Addington, Donald E., Mohamed, Somaia, Rosenheck, Robert A., Davis, Sonia M., Stroup, Thomas Scott, McEvoy, Joseph P., Swartz, Marvin S., Lieberman, Jeffrey A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5052810/
https://ncbi.nlm.nih.gov/pubmed/20868641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.09m05258gre
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!